A recent study suggests that fear and anxiety reflect overlapping set of neural building blocks in the brain.
The University of Maryland-led study, published in the Journal of Neuroscience, indicates that some long-accepted thinking about the basic neuroscience of anxiety is wrong.
The report by an international team of researchers led by Alexander Shackman, an associate professor of psychology at UMD, and Juyoen Hur, an assistant professor of psychology at Yonsei University in Seoul, South Korea, provides new evidence that fear and anxiety reflect overlapping brain circuits. The findings run counter to popular scientific accounts, highlighting the need for a major theoretical reckoning.
“The conceptual distinction between ‘fear’ and ‘anxiety’ dates back to the time of Freud, if not the Greek philosophers of antiquity,” said Shackman, a core faculty member of UMD’s Neuroscience and Cognitive Science Program, and 2018 recipient of a seed grant award from UMD’s Brain and Behaviour Initiative, “In recent years, brain imagers and clinicians have extended this distinction, arguing that fear and anxiety are orchestrated by distinct neural networks.”
However, Shackman said their new study adds to a rapidly growing body of new evidence suggesting that this old mode is wrong. “If anything, fear and anxiety seem to be constructed in the brain using a massively overlapping set of neural building blocks,” he said.
The prevailing scientific theory holds that fear and anxiety are distinct, with different triggers and strictly segregated brain circuits. Fear, a fleeting reaction to certain danger, is thought to be controlled by the amygdala, a small almond-shaped region buried beneath the wrinkled convolutions of the cerebral cortex. By contrast, anxiety, a persistent state of heightened apprehension and arousal elicited when threat is uncertain, is thought to be orchestrated by the neighbouring bed nucleus of the stria terminalis (BNST). But new evidence from Shackman and his colleagues suggest that both of these brain regions are equally sensitive to certain and uncertain kinds of threats.
Leveraging cutting-edge neuroimaging techniques available at the Maryland Neuroimaging Center, their research team used fMRI to quantify neural activity while participants anticipated receiving a painful shock paired with an unpleasant image and sound–a new task that the researchers dubbed the ‘Maryland Threat Countdown’.
The timing of this ‘threat’ was signalled either by a conventional countdown timer, that is, “3, 2, 1…” or by a random string of numbers e.g. “16, 21, 8.” In both conditions, threat anticipation recruited a remarkably similar network of brain regions, including the amygdala and the BNST. Across a range of head-to-head comparisons, the two showed statistically indistinguishable responses.
The team examined the neural circuits engaged while waiting for certain and uncertain threats (i.e. ‘fear’ and ‘anxiety’). Results demonstrated that both kinds of threat anticipation recruited a common network of core brain regions, including the amygdala and BNST.
These observations raise important questions about the Research Domain Criteria (RDoC) framework that currently guides the US National Institute of Mental Health’s quest to discover the brain circuitry underlying anxiety disorders, depression, and other common mental illnesses. “As it is currently written, RDoC embodies the idea that certain and uncertain threats are processed by circuits centered on the amygdala and BNST, respectively. It’s very black-and-white thinking,” Shackman noted, emphasizing that RDoC’s ‘strict-segregation’ model is based on data collected at the turn of the century.
“It’s time to update the RDoC so that it reflects the actual state of the science. It’s not just our study; in fact, a whole slew of mechanistic studies in rodents and monkeys, and new meta-analyses of the published human imaging literature are all coalescing around the same fundamental scientific lesson: certain and uncertain threat are processed by a shared network of brain regions, a common core,” he said.
As the crown jewel of NIMH’s strategic plan for psychiatric research in the US, the RDoC framework influences a wide range of biomedical stakeholders, from researchers and drug companies to private philanthropic foundations and foreign funding agencies. Shackman noted that the RDoC has an outsized impact on how fear and anxiety research is designed, interpreted, peer reviewed, and funded here in the US and abroad.
“Anxiety disorders impose a substantial and growing burden on global public health and the economy,” Shackman said, “While we have made tremendous scientific progress, existing treatments are far from curative for many patients. Our hope is that research like this study can help set the stage for better models of emotion and, ultimately, hasten the development of more effective intervention strategies for the many millions of children and adults around the world who struggle with debilitating anxiety and depression.”
(This story has been published from a wire agency feed without modifications to the text.)